Expression and relationship of PD-L1, CD24, and CD47 in hepatitis B virus associated hepatocellular carcinoma

Abstract Immune checkpoint inhibitor (ICI) therapy is the new standard treatment for advanced or metastatic hepatocellular carcinoma (HCC); however, many patients still fail to respond. This study explored the expression and prognosis of programmed death ligand 1 (PD-L1), cluster of differentiation...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Aiping Lin, Mingxia Wang, Zhihui Wang, Juan Lin, Zhihui Lin, Shaowei Lin, Shiyun Lu, Hong Lin, Haijun Tang, Xueping Huang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2024-12-01
coleção:	Scientific Reports
Assuntos:	HBV-associated hepatocellular carcinoma Immune checkpoint inhibitors PD-L1 CD24 CD47
Acesso em linha:	https://doi.org/10.1038/s41598-024-83145-5
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!